Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity

Annals of Neurology

Volumn 57, Issue 4, 2005, Pages 553-556

  Jokic, Natasa ^a   Gonzalez De Aguilar, Jose Luis ^a   Pradat, Pierre François ^b   Dupuis, Luc ^a   Echaniz Laguna, Andoni ^a,c   Muller, André ^a,c   Dubourg, Odile ^b   Seilhean, Danielle ^b   Hauw, Jean Jacques ^b   Loeffler, Jean Philippe ^a   Meininger, Vincent ^b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN NOGO; PROTEIN NOGO A; PROTEIN NOGO B; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MUSCLE; NERVE FIBER REGENERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE, SKELETAL; MYELIN PROTEINS; SEVERITY OF ILLNESS INDEX;

EID: 20144389664     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20420     Document Type: Article

References (19)

1. The ALS CNTF Treatment Study (ACTS) Phase I-II Study Group. The amyotrophic lateral sclerosis functional rating scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 1996;53:141-147.
2. Kalra S, Arnold DL, Cashman NR. Biological markers in the diagnosis and treatment of ALS. J Neurol Sci 1999;165 (suppl 1):S27-S32.
3. Oertle T, Schwab ME. Nogo and its paRTNers. Trends Cell Biol 2003;13:187-194.
4. Chen MS, Huber AB, van der Haar ME, et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000;403:434-439.
5. GrandPre T, Nakamura F, Vartanian T, Strittmatter SM. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 2000;403:439-444.
6. Fournier AE, GrandPre T, Strittmatter SM. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 2001;409:341-346.
7. Wang KC, Kim JA, Sivasankaran R, et al. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 2002;420:74-78.
8. Oertle T, van der Haar ME, Bandtlow CE, et al. Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J Neurosci 2003;23:5393-5406.
9. Merkler D, Metz GA, Raineteau O, et al. Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J Neurosci 2001;21:3665-3673.
10. GrandPre T, Li S, Strittmatter SM. Nogp-66 receptor antagonist peptide promotes axonal regeneration. Nature 2002;417: 547-551.
11. Dupuis L, Gonzalez de Aguilar JL, di Scala F, et al. Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis. Neurobiol Dis 2002;10:358-365.
12. Di Scala F, Dupuis L, Gaiddon C, et al. Tissue specificity and regulation of the amino-terminal diversity of reticulon 3. Biochem J 2005;385:125-134.
13. Guth L, Samaha FJ. Qualitative differences between actomyosin ATPase of slow and fast mammalian muscle. Exp Neurol 1969; 25:138-152.
14. Patten BM, Zito G, Harati Y. Histologic findings in motor neuron disease. Relation to clinically determined activity, duration, and seventy of disease. Arch Neurol 1979;36:560-564.
15. Iwasaki Y, Sugimoto H, Ikeda K, et al. Muscle morphometry in amyotrophic lateral sclerosis. Int J Neurosci 1991;58:165-170.
16. Gattenlöhner S, Schneider C, Thamer C, et al. Expression of foetal type acetylcholine receptor is restricted to type 1 muscle fibres in human neuromuscular disorders. Brain 2002;125: 1309-1319.
17. Huber AB, Weinmann O, Brosamle C, et al. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci 2002;22:3553-3567.
18. Pot C, Simonen M, Weinmann O, et al. Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury. J Cell Biol 2002;159:29-35.
19. Sicotte M, Tsatas O, Jeong SY, et al. Immunization with myelin or recombinant Nogo-66/MAG in alum promotes axon regeneration and sprouting after corticospinal tract lesions in the spinal cord. Mol Cell Neurosci 2003;23:251-263.